Nusantics
Nusantics is an Indonesian precision molecular diagnostics company that develops PCR- and NGS-based qPCR kits and laboratory testing services for human health (cervical cancer screening, respiratory pathogens) and shrimp aquaculture disease detection, serving hospitals, clinical labs, government programs, and shrimp farmers across Indonesia.
- Company typePrivate
- Founded2020
- HeadquartersJakarta, Indonesia
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Nusantics does
Nusantics (legally PT Riset Nusantara Genetika) is an Indonesian precision molecular diagnostics company founded in 2020 that designs, manufactures, and distributes PCR (Polymerase Chain Reaction) and NGS (Next Generation Sequencing)-based diagnostic products and services for both human and animal health. The company's core technology is its proprietary Fenrir Mastermix ReadyMix reagent system, which underpins a portfolio that includes the PathoScan hrHPV cervical cancer screening kit (with 96.55% sensitivity and 99.87% specificity versus the Roche Cobas 6800 comparator), the ShrimProtect family of qPCR kits detecting major shrimp pathogens (AHPND/EMS, WSSV, EHP, IMNV, IHHNV, DIV-1, YHV, TSV, plus multiplex panels), COVID-19 and respiratory pathogen kits (mBioCoV-19, VarScreen RxReady, BioSaliva), and the CeKolam independent shrimp disease testing laboratory offering PathoCheck, AquaCheck, ProCheck, and GutCheck services.
The company sells diagnostic kits on a one-time/perpetual license basis through distributors (PT. Biogen Scientific Indonesia), direct WhatsApp ordering, and the Indonesian government e-catalogue procurement platform, while generating fee-for-service revenue through CeKolam laboratory testing and professional-services revenue via healthcare screening collaborations (notably with PT Diagnos Laboratorium Utama across five cities). Its customer base spans healthcare providers and clinical laboratories (hospitals such as RSCM and Mandaya Hospital Group, plus multiple reference labs), government health programs supporting Indonesia's cervical cancer elimination plan, and the shrimp aquaculture value chain (hatcheries, feed mills, and farmers). Strategic backers include East Ventures as anchor investor, Illumina as technology partner, and Indonesia's state-owned Biofarma for manufacturing collaboration, with all products holding KEMENKES (human health) and KKP (aquaculture) regulatory certifications.
Nusantics firmographics
Firmographics- Name
- Nusantics
- Legal name
- PT Riset Nusantara Genetika
- Website
- https://nusantics.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Nusantics is an Indonesian precision molecular diagnostics company that develops PCR- and NGS-based qPCR kits and laboratory testing services for human health (cervical cancer screening, respiratory pathogens) and shrimp aquaculture disease detection, serving hospitals, clinical labs, government programs, and shrimp farmers across Indonesia.
- Ownership category
- akta.pro rank
Nusantics industry classification
Industry- Product category
- Molecular Diagnostics
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215), Testing Laboratories and Services (54138)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Molecular Diagnostics (PCR/qPCR, NGS-based assays) (HLAAALAA)
- akta.pro secondary industries
- Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Pathogen & Disease Diagnostics Services (Plant, Soil, Water) (AFACAKAG)
Keywords
Where Nusantics is headquartered
LocationHeadquarters
- HQ city
- Jakarta
- HQ country
- Indonesia
- HQ region
- Asia
Offices3 records
Markets served
Nusantics business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales
Revenue model
- Diagnostic Kit Sales: Sale of molecular diagnostic kits including PathoScan hrHPV, ShrimProtect series, mBioCoV-19, VarScreen RxReady, and BioSaliva for human and animal health applications. Kits are sold through distributors and direct ordering via WhatsApp and e-catalogue.
- Laboratory Testing Services (CeKolam): Fee-for-service testing through CeKolam independent laboratory providing Real-Time PCR and NGS-based disease detection for shrimp farmers, hatcheries, feed mills, and aquaculture stakeholders across Indonesia.
- Healthcare Screening Services: Collaboration with healthcare providers like PT Diagnos Laboratorium Utama for HPV DNA screening services, supporting national cervical cancer elimination programs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | Diagnostic kit products for clinical and research use |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels5 records
Nusantics product offering
Product offeringCore offering
Nusantics manufactures and sells proprietary PCR/qPCR and NGS-based molecular diagnostic kits for two verticals: human diagnostics (cervical cancer HPV screening via the PathoScan hrHPV kit using urine and cervical swab samples, plus SARS-CoV-2 and respiratory pathogen detection kits) and animal diagnostics (ShrimProtect family of shrimp pathogen detection kits). It also operates CeKolam, Indonesia's first independent shrimp disease testing laboratory offering fee-for-service Real-Time PCR and NGS testing.
Product overview
Nusantics is Indonesia's most established precision molecular diagnostics company offering a comprehensive portfolio of qPCR-based diagnostic products for human and animal health. The product portfolio includes HPV screening solutions (PathoScan hrHPV and PathoScan hrHPV Lite kits), respiratory disease testing (mBioCoV-19, VarScreen RxReady, BioSaliva), and shrimp disease detection (ShrimProtect family of qPCR kits including AHPND/EMS, WSSV, EHP, IMNV, DIV-1, IHHNV, YHV, TSV, and multiplex variants). Supporting products include the ShrimProtect X-Kit V2.0 for nucleic acid extraction. The CeKolam service brand provides independent laboratory testing services for shrimp farmers. All products utilize the proprietary Fenrir Mastermix technology.
Differentiator
Problem solved
Functional benefit
Brands
- PathoScan hrHPV: HPV DNA detection kit for cervical cancer screening using qPCR technology, detecting 14 high-risk HPV types from cervical swab and urine samples
- PathoScan hrHPV Lite
- ShrimProtect
- BioSaliva
- VarScreen RxReady
- mBioCoV-19
- ShrimProtect X-Kit V2.0
- CeKolam
- PathoCheck
- AquaCheck
- ProCheck
- GutCheck
Products and services
- PathoScan hrHPV qPCR Kit HPV DNA test kit using Nusantics' proprietary Fenrir Mastermix ReadyMix to detect 14 high-risk HPV types (HPV16, 18, 52, and others including 31, 33, 35, 39, 45, 51, 56, 58, 59, 66, 68) from cervical swab and urine samples in under 35 minutes. Achieves 96.55% sensitivity and 99.87% specificity for cervical swabs and is certified by KEMENKES RI (AKD 20306320321). Used by clinical laboratories and hospitals for cervical cancer screening.
- PathoScan hrHPV Lite qPCR Kit 4-channel qPCR variant of PathoScan hrHPV for laboratories with 4-channel instruments, detecting 14 high-risk HPV types and genotyping HPV16 and HPV18 from cervical swab and urine samples in under 35 minutes. Achieves 94.12% sensitivity and 99.77% specificity for cervical swabs. KEMENKES RI certified (AKD 20306420161).
- mBioCoV-19 qRT-PCR Kit COVID-19 qRT-PCR detection kit targeting SARS-CoV-2 nsp-12 (RdRP) and nsp-13 (helicase) genes. Detects all variants from Wild-Type to FLiRT. Produced by Biofarma as Indonesia's first locally made qRT-PCR test kit and certified by KEMENKES (AKD 20303021507). For use with NP, OP, NPOP swabs and gargle samples.
- VarScreen RxReady SARS-CoV-2 variant detection and differentiation kit using multiplex real-time PCR combining nsp-13 gene detection, 4 SGTF targets, and 1 ORF1ab 3675 deletion. Detects Alpha, Beta, Delta, Omicron, and Eris variants in under 55 minutes. KEMENKES RI certified (AKD 20303220035).
- BioSaliva Non-invasive gargle-based sample collection kit for SARS-CoV-2 and respiratory pathogen testing. Self-administered without medical personnel assistance, stable for 30 days at room temperature, with 91.38% sensitivity compared to NPOP swabs. KEMENKES certified (AKD 10302120673).
- ShrimProtect AHPND/EMS qPCR Kit Shrimp disease detection kit targeting pirA and pirB genes of AHPND/EMS-causing Vibrio parahaemolyticus in under 35 minutes, with 0.5-0.75 copies/µL limit of detection. NIE KKP RI certified (D 2212684 BBC). For shrimp farmers, hatcheries and aquaculture operators.
- ShrimProtect WSSV qPCR Kit Shrimp disease detection kit targeting the ORF167 gene of White Spot Syndrome Virus (WSSV) in under 35 minutes. NIE KKP RI certified (D 2212683 BBC).
- ShrimProtect EHP qPCR Kit Shrimp disease detection kit targeting the beta-tubulin gene of Enterocytozoon hepatopenaei (EHP) in under 35 minutes. NIE KKP RI certified (D 2306730 BBC).
- ShrimProtect IMNV qRT-PCR Kit Shrimp disease detection kit targeting the ORF1 gene of Infectious Myonecrosis Virus (IMNV) in under 45 minutes. NIE KKP RI certified (D 2305720 BBC).
- ShrimProtect DIV-1 qPCR Kit Shrimp disease detection kit targeting the ATPase gene of Decapod Iridescent Virus 1 (DIV-1) in under 35 minutes. NIE KKP RI certified (D 2406803 BBC).
- ShrimProtect IHHNV qPCR Kit Shrimp disease detection kit targeting Infectious Hypodermal and Haematopoietic Necrosis Virus (IHHNV) type 1 and 2 via the NSP target gene in under 35 minutes.
- ShrimProtect YHV qRT-PCR Kit Shrimp disease detection kit targeting the Replicase polyprotein 1ab gene of Yellow Head Virus (YHV) in under 45 minutes.
- ShrimProtect TSV qRT-PCR Kit Shrimp disease detection kit targeting the Capsid gene of Taura Syndrome Virus (TSV) in under 45 minutes. NIE KKP RI certified (D 2309755 BBC).
- ShrimProtect MultiGuard AHPND/EMS & EHP qPCR Kit Multiplex shrimp disease detection kit simultaneously detecting AHPND (pirA and pirB genes) and EHP (beta-tubulin gene) in under 35 minutes.
- ShrimProtect MultiGuard IHHNV, DIV1 & WSSV qPCR Kit Multiplex shrimp disease detection kit simultaneously detecting IHHNV, DIV1, and WSSV in under 35 minutes.
- ShrimProtect X-Kit V2.0 Silica-based spin column nucleic acid extraction kit for total nucleic acid (DNA and RNA) from shrimp and water samples, with sample processing of 30-40 minutes for 9 samples. Used as an accessory to the ShrimProtect qPCR kit family.
- CeKolam Independent Shrimp Disease Testing Laboratory Indonesia's first independent laboratory for shrimp disease testing, offering Real-Time PCR and Next Generation Sequencing services. Service offerings include PathoCheck (rapid pathogen detection with same-day results), AquaCheck (water microbiome mapping with NGS), ProCheck (probiotic quality and purity testing using NGS), and GutCheck (gut microbiome monitoring for shrimp growth and resilience). Targeted at shrimp farmers, hatcheries, feed mills, and aquaculture companies that lack in-house laboratory facilities.
Quantifiable outcome
- PathoScan hrHPV achieves 96.55% sensitivity and 99.87% specificity for cervical swabs compared to FDA-approved HPV DNA kits
- +2 more outcomes
Companies that use Nusantics
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles3 records
Nusantics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature7 records
Nusantics partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and minor.
- IlluminacoreIllumina is a global leader in sequencing and array-based technologies. Partnership enables Nusantics to leverage Illumina's platform capabilities for Next Generation Sequencing applications in diagnostics.
- BiofarmacoreBiofarma is Indonesia's state-owned pharmaceutical and biotechnology company. Biofarma produced the mBioCoV-19 qRT-PCR Kit as the first locally made COVID-19 test kit in Indonesia.
- Kementerian Kesehatan (Ministry of Health Indonesia)corePartnership to support Indonesia's National Action Plan (RAN) for Cervical Cancer Elimination (2023-2030) by providing PathoScan hrHPV qPCR Kit for HPV screening programs.
- Kementerian Kelautan dan Perumahan (KKP/Ministry of Marine Affairs and Fisheries)coreCollaboration to launch ShrimProtect test kits and CeKolam laboratory services for shrimp disease detection, supporting Indonesia's aquaculture industry biosecurity.
- PT Diagnos Laboratorium UtamacoreCollaboration for HPV DNA screening using PathoScan hrHPV with urine sample collection. Services available at Diagnos branches in Jakarta, Makassar, Denpasar, Padang, and Batam, as well as partner hospitals.
- Mandaya Hospital GroupminorHealthcare provider partner for offering diagnostic services to patients
- Rumah Sakit Dr. Cipto Mangunkusumo (RSCM)minorIndonesia's leading national referral hospital for medical services and collaboration
- PT. Biogen Scientific IndonesiacoreOfficial distributor for Nusantics diagnostic products including PathoScan hrHPV kits through their network across Indonesia
- Sumber Hatchery BangkaminorShrimp hatchery customer using ShrimProtect test kits for 1.5 years to test larvae, feed, and worms with reported improved sensitivity and accuracy
- InnoquestminorPartner laboratory for diagnostic services
- Bio MedikaminorLaboratory partner for diagnostic services
- IANDV BiominorPartner for diagnostic products and services
- Suri Tani PemukaminorAquaculture industry partner for shrimp health solutions
- Central Proteina PrimaminorProtein and aquaculture industry partner
- CJ Feed & CareminorFeed and animal care company partner in the aquaculture ecosystem
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
Nusantics competitors and assessment
Company assessmentDirect peers
- Biofarma: Indonesia's state-owned pharmaceutical and biotechnology company. Direct comparator because Biofarma manufactured Nusantics' mBioCoV-19 qRT-PCR kit and competes in the same Indonesian domestic molecular diagnostics space with government procurement access.
- Yourgene Health: UK-based molecular diagnostics company specializing in women's health (non-invasive prenatal testing, HPV) and aquaculture genetics. Closely comparable to Nusantics' dual human health + animal health diagnostics model with similar technology focus.
Broad incumbents
- Roche Diagnostics: Global molecular diagnostics leader with the Cobas 6800 HPV system against which PathoScan hrHPV was validated. Offers broad HPV, infectious disease, and oncology molecular diagnostics; Nusantics' core technology competes head-on with Roche in the Indonesian HPV screening market.
- Hologic: Women's health molecular diagnostics leader with the Aptima HPV assay. Comparable in that both companies focus on high-risk HPV detection and cervical cancer screening workflows, though Hologic operates as a broad incumbent with global reach.
- Cepheid (Danaher): GeneXpert molecular diagnostics platform owned by Danaher. Provides comparable rapid PCR-based diagnostics for infectious diseases and women's health; represents a multinational incumbent Nusantics competes against in Indonesian hospital and laboratory settings.
- Qiagen: Sample preparation and molecular diagnostics company offering PCR and NGS workflows. Comparable in PCR/qPCR kit development for infectious disease and oncology applications, with much broader global portfolio than Nusantics.
Emerging players
- Sansure Biotech: Chinese molecular diagnostics company with an extensive infectious disease PCR portfolio including HPV, respiratory pathogens, and variant detection. Comparable product architecture and Asian emerging-market positioning to Nusantics.
- Bioneer: Korean molecular diagnostics company developing PCR-based kits for infectious diseases and genetic testing. Comparable in PCR reagent kit development, focus on Asian markets, and product portfolio breadth across human diagnostics.
- Medicox: Korean molecular diagnostics company specializing in aquatic animal disease detection including shrimp pathogens. Comparable on the aquaculture/animal health diagnostics side of Nusantics' ShrimProtect portfolio.
Regional players
- Speedy Assay: Thai molecular diagnostics company providing PCR-based testing kits for infectious diseases and genetic conditions in Southeast Asia. Comparable regional emerging-market positioning and ASEAN distribution model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Nusantics social profiles
Digital presenceNusantics financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nusantics leadership team
Management profileNumber of profiles
Profiles1 record
Nusantics subsidiaries and ownership
Company hierarchySubsidiaries1 record
Nusantics funding detail
Funding detailFunding overview
Funding rounds3 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nusantics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nusantics
What does Nusantics do?
Nusantics manufactures and sells proprietary PCR/qPCR and NGS-based molecular diagnostic kits for two verticals: human diagnostics (cervical cancer HPV screening via the PathoScan hrHPV kit using urine and cervical swab samples, plus SARS-CoV-2 and respiratory pathogen detection kits) and animal diagnostics (ShrimProtect family of shrimp pathogen detection kits). It also operates CeKolam, Indonesia's first independent shrimp disease testing laboratory offering fee-for-service Real-Time PCR and NGS testing.
Is Nusantics a public or private company?
Nusantics is a private company. It is classified as venture growth investor backed and is currently operating.
When was Nusantics founded?
Nusantics was founded in 2020. It employs 51 to 100 people.
Where is Nusantics based?
Nusantics is headquartered in Jakarta, Indonesia, in the Asia region.
How does Nusantics make money?
Three revenue lines are on record. Diagnostic Kit Sales are the primary driver. The others are laboratory Testing Services (CeKolam) and healthcare Screening Services.
Who are Nusantics's main competitors?
Direct peers on record are Biofarma and Yourgene Health. Broad incumbents are Roche Diagnostics, Hologic, Cepheid (Danaher) and Qiagen. Emerging players are Sansure Biotech, Bioneer and Medicox. Speedy Assay is listed as a regional player.
Does Nusantics have an API?
No public API is recorded for Nusantics.
What industry is Nusantics in?
Nusantics's product category is Molecular Diagnostics. Its primary akta.pro industry code is HLAAALAA, Molecular Diagnostics (PCR/qPCR, NGS-based assays), with a secondary code of HLAMADAC, Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology). Its NAICS code is 621511 and its SIC code is 2835.